Cervical, vaginal and vulvar cancer incidence and survival trends in Denmark, Finland, Norway and Sweden with implications to treatment

Por Kari Hemminki, Anna Kanerva, Asta Försti, Akseli Hemminki
Publicado em 2022-04-01

Familial Risks for Liver, Gallbladder and Bile Duct Cancers and for Their Risk Factors in Sweden, a Low-Incidence Country

Por Kari Hemminki, Kristina Sundquist, Jan Sundquist, Asta Försti, Vaclav Liska, Akseli Hemminki, Xinjun Li
Publicado em 2022-04-01

TNFa and IL2 Encoding Oncolytic Adenovirus Activates Pathogen and Danger-Associated Immunological Signaling

Por Camilla Heiniö, Riikka Havunen, Joao Santos, Klaas de Lint, Victor Cervera-Carrascon, Anna Kanerva, Akseli Hemminki
Publicado em 2020-03-01

Calcium gluconate in phosphate buffered saline increases gene delivery with adenovirus type 5.

Por Marko T Ahonen, Iulia Diaconu, Sari Pesonen, Anna Kanerva, Marc Baumann, Suvi T Parviainen, Brad Spiller, Vincenzo Cerullo, Akseli Hemminki
Publicado em 2010-09-01

Toxicological and bio-distribution profile of a GM-CSF-expressing, double-targeted, chimeric oncolytic adenovirus ONCOS-102 - Support for clinical studies on advanced cancer treatm...

Por Lukasz Kuryk, Lotta Vassilev, Tuuli Ranki, Akseli Hemminki, Aila Karioja-Kallio, Onerva Levälampi, Antti Vuolanto, Vincenzo Cerullo, Sari Pesonen
Publicado em 2017-01-01

Cancer Predisposition Genes in Cancer-Free Families

Por Guoqiao Zheng, Calogerina Catalano, Obul Reddy Bandapalli, Nagarajan Paramasivam, Subhayan Chattopadhyay, Matthias Schlesner, Rolf Sijmons, Akseli Hemminki, Dagmara Dymerska, Jan Lubinski, Kari Hemminki, Asta Försti
Publicado em 2020-09-01

Intravenously usable fully serotype 3 oncolytic adenovirus coding for CD40L as an enabler of dendritic cell therapy

Por Sadia Zafar, Suvi Parviainen, Mikko Siurala, Otto Hemminki, Riikka Havunen, Siri Tähtinen, Simona Bramante, Lotta Vassilev, Hongjie Wang, Andre Lieber, Silvio Hemmi, Tanja de Gruijl, Anna Kanerva, Akseli Hemminki
Publicado em 2017-02-01

T-cell Subsets in Peripheral Blood and Tumors of Patients Treated With Oncolytic Adenoviruses

Por Kristian, Taipale, Ilkka, Liikanen, Juuso, Juhila, Aila, Karioja-Kallio, Minna, Oksanen, Riku, Turkki, Nina, Linder, Johan, Lundin, Ari, Ristimäki, Anna, Kanerva, Anniina, Koski, Timo, Joensuu, Markus, Vähä-Koskela, Akseli, Hemminki
Publicado no Mol Ther (2015)

Comparison of Clinically Relevant Oncolytic Virus Platforms for Enhancing T Cell Therapy of Solid Tumors

Por Victor Cervera-Carrascon, Dafne C.A. Quixabeira, Riikka Havunen, Joao M. Santos, Emma Kutvonen, James H.A. Clubb, Mikko Siurala, Camilla Heiniö, Sadia Zafar, Teija Koivula, Dave Lumen, Marjo Vaha, Arturo Garcia-Horsman, Anu J. Airaksinen, Suvi Sorsa, Marjukka Anttila, Veijo Hukkanen, Anna Kanerva, Akseli Hemminki
Publicado em 2020-06-01